The Global Brain Cancer Diagnostics Market is expected to grow with a CAGR of 18.9% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-brain-cancer-diagnostic-market
The global brain cancer diagnostics market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to a favorable market scenario.
Some of the major players dealing in the global brain cancer diagnostics market are introducing a wide range of products along with adopting strategic initiatives such as acquisitions, agreements, business expansions, approvals and awards and recognitions into the market. This helps the companies maximize their sales with enhanced product portfolio.
For instance,
- In November 2022, BD has announced to grant USD 652,000 to Valley-Mount Sinai Comprehensive Cancer Care to increase diversity, equity and inclusion in cancer clinical trials.
- In August 2022, BD, a leading global medical technology company & Accelerate Diagnostics, Inc., an innovator of rapid in-vitro diagnostics in microbiology, have announced a worldwide commercial collaboration agreement.
Koninklijke Philips N.V. is the dominating player in the global brain cancer diagnostics market. The other key players existing in the market include CANON MEDICAL SYSTEMS CORPORATION, Siemens Healthcare GmbH, BD, NIHON KOHDEN CORPORATION., Biocept, Inc., BioMind, Cerebral Diagnostics, Dxcover Limited, FONAR Corp., FUJIFILM Holdings Corporation, GE HealthCare, Hitachi, Ltd, MinFound Medical Systems Co., Ltd, NantOmics, Neusoft Corporation, Sequoia Healthcare, SternMed GmbH, Thermo Fisher Scientific Inc. and Time Medical Holding, among others.
Koninklijke Philips N.V.
Koninklijke Philips N.V. was founded in the year 1891 and is headquartered in Amsterdam, Netherlands. The company focuses on improving people’s health and well-being through meaningful innovation. The company has product categories such as Advance Molecular Nuclear Imaging, Computed tomography, customer services solutions, diagnostic ECG fluoroscopy, Image-guided therapy, MRI systems & solutions, patient monitoring solutions, Radiography/X-Ray & fluoroscopy solutions, among others, in which market focused categories are MRI systems and solution and computed tomography. The company is engaged in the development of brain cancer diagnostics.
For instance,
- In November 2022, Koninklijke Philips N.V. announced its advances in AI-powered diagnostic systems and transformative workflow solutions at RSNA 2022. The latest systems and informatics solutions are designed for providers to efficiently deliver patient-centric, high-quality imaging services. This helps the company to increase its global presence of the company as well as helps in revenue expansion.
The company has a wide presence across Asia-Pacific, North America, Europe, South America & Middle East and Africa. The company has various subsidiaries, such as Philips Argentina Sociedad Anonima (Argentina), Philips Domestic Appliances Australia Pty Ltd (Australia), Philips Vietnam Limited (Vietnam), and Philips Uruguay S.A. (Uruguay), among others.
Canon Inc.
Canon Inc. was founded in the year 1933 and is headquartered in California, U.S. The company focuses on delivering innovative imaging solutions and services through its Made for life philosophy to improve the quality of life for all people. The company has product categories such as Angiography, Computed Tomography, Molecular Imaging, Magnetic Resonance, Ultrasound, X-ray, Healthcare it and Eye Care in which market focused categories are Computed Tomography, Angiography and Magnetic Resonance.
For instance,
- In November 2022, Canon Inc. announced that it had strengthened its medical business with the establishment of Canon Healthcare USA, INC. This helps the organization accelerate the growth of its medical business.
The company has a wide presence across Asia-Pacific, North America, Europe, South America & Middle East and Africa. The company has various subsidiaries, such as Canon Medical Systems Corporation (Japan), Canon Electronics Inc. (Japan), and Nagahama Canon Inc. (Japan), among others.
Siemens Healthcare GmbH
Siemens Healthcare GmbH was founded in the year 1847 and is headquartered in Erlangen, Germany. The company focuses on breakthrough innovations to market to help healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. The company has product categories such as Medical Imaging, Varian-Cancer Care, Laboratory Diagnostics, Point-Of-Care Testing, Digital Health Solutions, Value Partnerships & Consulting Services, Accessories, OEM & Electronics, Healthcare IT in which market focused category is Medical Imaging, Varian-Cancer Care and Laboratory Diagnostics.
For instance,
- In November 2022, Siemens Healthcare GmbH has manufactured the first Halcyon radiotherapy system at its Kemnath site following the successful integration of Varian. This has helped the company to expand its product portfolio.
The company has a wide presence across Asia-Pacific, North America, Europe, South America & Middle East and Africa.
